Detection of heterogeneous vancomycin intermediate resistance in MRSA isolates from Latin America

BACKGROUND: Vancomycin is a common first-line option for MRSA infections. The heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) phenotype is associated with therapeutic failure. However, hVISA isolates are usually reported as vancomycin susceptible by routine susceptibility testing...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Antimicrob Chemother
Hlavní autoři: Castro, Betsy E, Berrio, Maritza, Vargas, Monica L, Carvajal, Lina P, Millan, Lina V, Rios, Rafael, Hernandez, Angie K, Rincon, Sandra, Cubides, Paola, Forero, Erika, Dinh, An, Seas, Carlos, Munita, Jose M, Arias, Cesar A, Reyes, Jinnethe, Diaz, Lorena
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2020
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7443737/
https://ncbi.nlm.nih.gov/pubmed/32562543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkaa221
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky